Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Biomaterials
Evonik purchases medical start-up
by Alexander H. Tullo
August 7, 2021
| A version of this story appeared in
Volume 99, Issue 29
Evonik has purchased the German start-up JeNaCell, which makes biotechnologically derived cellulose for medical applications. Evonik’s venture capital arm invested in JeNaCell in 2015 and now plans to pair the firm with its Resomer bioresorbable polymers, used in medical implants. JeNaCell is a spinoff of the Friedrich Schiller University of Jena. Its films are being used as dressings for chronic wounds, surgical wounds, and burns.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter